Skip to content
  • Home
  • Leadership
  • Locations
  • Careers
  • Investors
    • Media
    • Press Releases
    • SEC Filings
    • Governance
      • Board Committee
      • Board of Directors
      • Governance Documents
    • Investor Relations Contacts
    • Investor Materials
    • Analyst Coverage
      • Benchmark – Bill Sutherland
      • Maxim Group – Anthony Vendetti
      • Freedom Capital Markets – Gene Mannheimer
  • Contact
Nutex Health
  • Home
  • Leadership
  • Locations
  • Careers
  • Investors
    • Media
    • Press Releases
    • SEC Filings
    • Governance
      • Board Committee
      • Board of Directors
      • Governance Documents
    • Investor Relations Contacts
    • Investor Materials
    • Analyst Coverage
      • Benchmark – Bill Sutherland
      • Maxim Group – Anthony Vendetti
      • Freedom Capital Markets – Gene Mannheimer
  • Contact

Posts in August 14, 2025

by 919496pwpadmin
August 14, 2025

NUTEX HEALTH PROVIDES PRELIMINARY SECOND QUARTER FINANCIAL RESULTS, ANNOUNCES DELAY IN FILING ITS 2025 SECOND QUARTER FINANCIAL STATEMENTS AND ANNOUNCES A STOCK REPURCHASE PROGRAM OF UP TO $25 MILLION

HOUSTON, Aug. 14, 2025 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), […]
0
read more
  • X (twitter)
  • facebook
  • linked in

1776 Yorktown St Suite 700

Houston, TX 77056

713-660-0557

info@nutexhealth.com

  • Home
  • Investors
  • Contact
  • Whistleblower
  • Home
  • Investors
  • Contact
  • Whistleblower

© 2026

Sign Up for Investor News & More

email alerts
© 2026 Nutex Health